These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19182504)

  • 1. Induction of upregulation and downregulation of the T-cell activation marker CD98 in patients undergoing contrast-enhanced CT with iodinated non-ionic dimeric contrast medium.
    Böhm I; Schild HH
    Korean J Radiol; 2009; 10(1):58-62. PubMed ID: 19182504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iosimenol, a new non-ionic dimeric contrast medium, does not induce immunoreactivity in the popliteal lymph node assay.
    Fernandez Cabezudo MJ; Petroianu G; Al-Ramadi B; Langer RD
    Br J Radiol; 2007 Sep; 80(957):713-8. PubMed ID: 17768167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-arterial and intravenous applications of Iosimenol 340 injection, a new non-ionic, dimeric, iso-osmolar radiographic contrast medium: phase 2 experience.
    Meurer K; Laniado M; Hosten N; Kelsch B; Hogstrom B
    Acta Radiol; 2015 Jun; 56(6):702-8. PubMed ID: 24938661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study on basophil activation induced by contrast medium.
    Böhm I; Speck U; Schild HH
    Fundam Clin Pharmacol; 2011 Apr; 25(2):267-76. PubMed ID: 20412314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine profiles after nonionic dimeric contrast medium injection.
    Böhm I; Speck U; Schild H
    Invest Radiol; 2003 Dec; 38(12):776-83. PubMed ID: 14627895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iosimenol, a low-viscosity nonionic dimer: preclinical physicochemistry, pharmacology, and pharmacokinetics.
    Sovak M; Terry R; Abramjuk C; Faberová V; Fiserova M; Laznicek M; Leuschner J; Malinak J; Zahradnik P; Masner O; Seligson A
    Invest Radiol; 2004 Mar; 39(3):171-81. PubMed ID: 15076009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-ionic iodinated dimeric versus monomeric X-ray contrast media: effects on complement factors in vivo].
    Böhm I; Speck U; Schild H
    Rofo; 2006 Mar; 178(3):306-12. PubMed ID: 16508838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of non-ionic iodinated contrast media on patient heart rate and pressures during intra-cardiac or intra-arterial injection.
    Schmid I; Didier D; Pfammatter T; Garachemani A; Fleisch M; Kirchin MA; Meier B
    Int J Cardiol; 2007 Jun; 118(3):389-96. PubMed ID: 17376548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical association and functional interaction between beta1 integrin and CD98 on human T lymphocytes.
    Miyamoto YJ; Mitchell JS; McIntyre BW
    Mol Immunol; 2003 Jan; 39(12):739-51. PubMed ID: 12531285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of viscosity on power and hand injection of iso-osmolar iodinated contrast media through thin catheters.
    Zhang JJ; Hogstrom B; Malinak J; Ikei N
    Acta Radiol; 2016 May; 57(5):557-64. PubMed ID: 26185266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodixanol. A review of its pharmacodynamic and pharmacokinetic properties and diagnostic use as an x-ray contrast medium.
    Spencer CM; Goa KL
    Drugs; 1996 Dec; 52(6):899-927. PubMed ID: 8957160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of renal function with delayed CT after injection of nonionic monomeric and dimeric contrast media in healthy volunteers.
    Jakobsen JA; Lundby B; Kristoffersen DT; Borch KW; Hald JK; Berg KJ
    Radiology; 1992 Feb; 182(2):419-24. PubMed ID: 1732960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of late allergy-like adverse reactions following injection of intravascular non-ionic contrast media. A retrospective study comparing a non-ionic monomeric contrast medium with a non-ionic dimeric contrast medium.
    Rydberg J; Charles J; Aspelin P
    Acta Radiol; 1998 May; 39(3):219-22. PubMed ID: 9571932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of iodixanol, a new isotonic contrast agent, on femoral blood flow in man.
    Pugh ND; Sissons GR; Ruttley M
    Clin Radiol; 1992 Apr; 45(4):243-5. PubMed ID: 1395379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of non-ionic monomeric and dimeric iodinated contrast media on renal and systemic haemodynamics in rats.
    Idée JM; Lancelot E; Berthommier C; Couturier-Goulas V; Vazin V; Corot C
    Fundam Clin Pharmacol; 2000; 14(1):11-8. PubMed ID: 10681069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast medium attenuates platelet activation and platelet-leukocyte cross-talk.
    Ji Q; Ghaly M; Hjemdahl P; Tornvall P; Li N
    Thromb Haemost; 2005 May; 93(5):922-6. PubMed ID: 15886810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which iodinated contrast media is the least cytotoxic to human disc cells?
    Kim KH; Park JY; Park HS; Kuh SU; Chin DK; Kim KS; Cho YE
    Spine J; 2015 May; 15(5):1021-7. PubMed ID: 25634786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of iodixanol on renal function immediately after abdominal angiography. Clinical comparison with iomeprol and ioxaglate.
    Murakami R; Tajima H; Kumazaki T; Yamamoto K
    Acta Radiol; 1998 Jul; 39(4):368-71. PubMed ID: 9685820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of the brain with a nonionic, dimeric, iso-osmolal contrast medium.
    Langner S; Stumpe S; Kirsch M; Petrik M; Hosten N
    AJNR Am J Neuroradiol; 2008 Sep; 29(8):1525-9. PubMed ID: 18524974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergence between CD98 and integrin-mediated T-lymphocyte co-stimulation.
    Warren AP; Patel K; Miyamoto Y; Wygant JN; Woodside DG; McIntyre BW
    Immunology; 2000 Jan; 99(1):62-8. PubMed ID: 10651942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.